Id |
Subject |
Object |
Predicate |
Lexical cue |
T3706 |
0-9 |
NNP |
denotes |
Rationale |
T87509 |
9-10 |
-COLON- |
denotes |
: |
T72411 |
11-22 |
NNP |
denotes |
Tocilizumab |
T46139 |
23-26 |
MD |
denotes |
can |
T80638 |
27-32 |
VB |
denotes |
treat |
T14365 |
33-37 |
NN |
denotes |
lung |
T88114 |
38-44 |
NN |
denotes |
injury |
T76208 |
45-47 |
IN |
denotes |
in |
T24628 |
48-56 |
NNS |
denotes |
patients |
T15777 |
57-61 |
IN |
denotes |
with |
T58130 |
62-70 |
JJ |
denotes |
critical |
T31522 |
71-74 |
CC |
denotes |
and |
T55163 |
75-81 |
JJ |
denotes |
severe |
T92225 |
82-90 |
NN |
denotes |
COVID-19 |
R20598 |
T55163 |
T31522 |
arg2Of |
severe,and |
R21368 |
T24628 |
T15777 |
arg1Of |
patients,with |
R29604 |
T88114 |
T80638 |
arg2Of |
injury,treat |
R37530 |
T80638 |
T46139 |
arg2Of |
treat,can |
R4477 |
T92225 |
T55163 |
arg1Of |
COVID-19,severe |
R69456 |
T24628 |
T76208 |
arg2Of |
patients,in |
R76550 |
T58130 |
T31522 |
arg1Of |
critical,and |
R76769 |
T92225 |
T58130 |
arg1Of |
COVID-19,critical |
R79687 |
T92225 |
T15777 |
arg2Of |
COVID-19,with |
R82985 |
T80638 |
T76208 |
arg1Of |
treat,in |
R84332 |
T3706 |
T87509 |
arg1Of |
Rationale,: |
R86004 |
T72411 |
T46139 |
arg1Of |
Tocilizumab,can |
R90482 |
T88114 |
T14365 |
arg1Of |
injury,lung |
R92198 |
T72411 |
T80638 |
arg1Of |
Tocilizumab,treat |